Free Access
Med Sci (Paris)
Volume 21, Number 5, Mai 2005
Page(s) 498 - 502
Section M/S revues
Published online 15 May 2005
  1. Woessner JF, Taplin CJ. Purification and properties of a small latent matrix metalloproteinase of the rat uterus. J Biol Chem 1998; 263 : 16918–25. [Google Scholar]
  2. Imai K, Yokohama Y, Nakanishi I, et al. Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor interaction with other matrix metalloproteinases and enzymic properties. J Biol Chem 1995; 270 : 6691–7. [Google Scholar]
  3. Powell WC, Domann FE Jr, Mitchen JM, et al. Matrilysin expression in the involuting ventral prostate. Prostate 1996; 29 : 159–68. [Google Scholar]
  4. Wilson CL, Heppner KJ, Labosky PA, et al. Intestinal tumorigenesis is suppressed in mice lacking the metalloprotease matrilysin. Proc Natl Acad Sci USA 1997; 94 : 1402–7. [Google Scholar]
  5. Newell KJ, Matrisian LM, Driman DK. Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis. Mol Carcinol 2002; 34 : 59–63. [Google Scholar]
  6. Matsuno K, Adachi Y, Yamamoto H, et al. The expression of matrix metalloproteinase matrilysin indicates the degree of inflammation in ulcerative colitis. J Gastroenterol 2003; 38 : 348–54. [Google Scholar]
  7. Yamashita K, Azumano I, Mai M, Okada Y. Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinoma. Implication for vessel invasion and metastasis. Int J Cancer 1998; 79 : 187–94. [Google Scholar]
  8. Salmela MT, Karjalainen-Lindsberg ML, Puolakkainen P, Saarialho-Kere U. Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett’s oesophageal adenocarcinoma. Br J Cancer 2001; 85 : 383–92. [Google Scholar]
  9. Tanioka Y, Yoshida T, Ygawa T, et al. Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer. Br J Cancer 2003; 89 : 2116–21. [Google Scholar]
  10. Yamamoto H, Adachi Y, Itoh F, et al. Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer Res 1999; 59 : 3313–16. [Google Scholar]
  11. Ishikawa T, Ichikawa Y, Mitsuhashi M, et al. Matrilysin is associated with progression of colorectal tumor. Cancer Lett 1996; 107 : 5–10. [Google Scholar]
  12. Masaki T, Sugiyama M, Matsuoka H, et al. Coexpression of matrilysin and laminin-5 gamma2 chain may contribute to tumor cell migration in colorectal carcinomas. Dig Dis Sci 2003; 48 : 1262–67. [Google Scholar]
  13. Kioi M, Yamaoto K, Higashi S, et al. Matrilysin (MMP7) induces homotypic adhesion of human colon cancer cells and enhances their metastatic potential in nude mouse model. Oncogene 2003; 22 : 8662–70. [Google Scholar]
  14. Weinfass B, Nejjari M, Trespeuch C, et al. Effets de la bombésine sur l’expression de la matrilysine MMP7 dans la lignée cancéreuse colique humaine Isreco 1. Gastroenterol Clin Biol 2004; 28 : 161. [Google Scholar]
  15. Wroblewski LE, Noble PJM, Pagliocca A, et al. Stimulation of MMP-7 (matrilysin) by Helicobacter pylori in human gastric epithelial cells : role in epithelial cell migration. J Cell Sci 2003; 116 : 3017–26. [Google Scholar]
  16. Nagashima Y, Hasegawa S, Koshikawa N, et al. Expression of matrilysin in vascular endothelial cells adjacent to matrilysin-producing tumors. Int J Cancer 1997; 72 : 441–5. [Google Scholar]
  17. Huo N, Ichikawa Y, Kamiyama M, et al. MMP7 (matrilysin) accelerated growth of human umbilical vein endothelial cells. Cancer Lett 2002; 177 : 95–100. [Google Scholar]
  18. Pozzi A, Moberg PE, Miles LA, et al. Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. Proc Natl Acad Sci USA 2000; 97 : 2202–7. [Google Scholar]
  19. Fingleton B, Vargo-Gogola T, Crawford HC, Matrisian LM. Matrilysin (MMP-7) expression selects for cells with reduced sensitivity to apoptosis. Neoplasia 2001; 3 : 459–68. [Google Scholar]
  20. Davies G, Jiang WG, Mason MD. Matrilysin mediates extracellualr cleavage of E-cadherin from prostate cancer cells : a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion. Clin Canc Res 2001; 7 : 3289–97. [Google Scholar]
  21. McGuire J, Li Q, Parks WC. Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium. Am J Pathol 2003; 162 : 1831–43. [Google Scholar]
  22. Wilson CL, Matrisian LM. Matrilysin : an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol 1996; 28 : 123–36. [Google Scholar]
  23. Von Bredow DC, Nagle RB, Bowden GT, Cress AE. Cleavage of béta4 integrin by matrilysin. Exp Cell Res 1997; 236 : 341–5. [Google Scholar]
  24. Bair EL, Massey CP, Tran NL, et al. Integrin- and cadherin-mediated induction of the matrix metalloprotease matrilysin in cocultures of malignant oral squamous cell carcinoma cells and dermal fibroblasts. Exp Cell Res 2001; 270 : 259–67. [Google Scholar]
  25. Leeman MF, Curran S, Murray GI. New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression. J Pathol 2003; 201 : 528–34. [Google Scholar]
  26. Brabletz T, Jung A, Dag S, et al. β-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 1999; 155 : 1033–8. [Google Scholar]
  27. Ougolkov AV, Yamashita K, Mai M, Minamoto T. Oncogenic béta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer. Gastroenterology 2002; 122 : 60–71. [Google Scholar]
  28. Brabletz T, Jung A, Kirchner T. β-catenin and the morphogenesis of colorectal cancer. Virchows Arch 2002; 441 : 1–11. [Google Scholar]
  29. Ozaki I, Mizuta T, Yotsumoto H, et al. Involvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma. Cancer Res 2000; 60 : 19–25. [Google Scholar]
  30. Udayakumar TS, Stratton MS, Nagle RB, Bowden GT. Fibroblast growth factor-1 induced promatrilysin expression through the activation of extracellular regulated kinases and STAT3. Neoplasia 2002; 4 : 60–7. [Google Scholar]
  31. Lynch CC, Crawford HC, Matrisian LM, McDonnell S. Epidermal growth factor upregulates matrix metalloproteinase-7 expression through activation of PEA3 transcription factors. Int J Oncol 2004; 24 : 1565–72. [Google Scholar]
  32. Yamamoto H, Iku S, Adachi Y, et al. Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer. J Pathol 2003; 199 : 176–184. [Google Scholar]
  33. Ueno H, Yamashita K, Azumano I, et al. Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinoma. Int J Cancer 1999; 84 : 470–7. [Google Scholar]
  34. Yu WH, Woessner JF Jr. Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7). J Biol Chem 2000; 275 : 4183–91. [Google Scholar]
  35. Shiomi T, Okada Y. MT1-MMP and MMP-7 in invasion and metastasis of human cancers. Cancer Met Rev 2003; 22 : 145–52. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.